Understand the source comparison
Best Follistatin-344 Dosage Body Composition 2026: Protocol Comparison
100mcg daily (fasted AM) Lean mass preservation during deficit 4–8 weeks Baseline myostatin suppression without hypertrophic stimulus Bacteriostatic water, 2–8°C storage, 28-day use window Effective for anti-catabolic research; less suited for active hypertrop
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- 100mcg daily (fasted AM)
- Lean mass preservation during deficit
- 4–8 weeks
- Baseline myostatin suppression without hypertrophic stimulus
- Bacteriostatic water, 2–8°C storage, 28-day use window
- Effective for anti-catabolic research; less suited for active hypertrophy protocols
- 200mcg daily (post-training + fasted rest days)
- Hypertrophy and recomposition during structured resistance training
- 8–12 weeks
- Acute post-exercise myostatin inhibition + circadian peak suppression
- Pharmaceutical-grade bacteriostatic water, strict cold chain, no temperature excursions
- Most common protocol in published research; balance of efficacy and peptide stability
- 250–300mcg daily (post-training only)
- Accelerated recovery from atrophy or injury
- 4–6 weeks
- Maximal receptor occupancy during anabolic window
- Medical-grade reconstitution under sterile conditions, verified amino-acid sequencing
- Diminishing returns above 250mcg; higher contamination risk with frequent vial access
- 150mcg every other day
- Long-duration protocols (>12 weeks)
- 12–16 weeks
- Extended myostatin suppression with reduced injection frequency
- Standard bacteriostatic water, refrigerated storage
- Lower total peptide volume; less alignment with training cycles
- The 200mcg daily post-training protocol remains the standard in 2026 research because it aligns peptide binding with both acute myostatin expression (post-exercise) and circadian myostatin peaks (fasted morning). Protocols using higher doses without addressing reconstitution sterility or storage precision consistently underperform lower-dose protocols executed with pharmaceutical-grade technique.